Devil in the milk : illness, health and politics : A1 and A2 milk / Keith Woodford.

By:

Woodford, K. B

Material type: Text

TextPublication details: Nelson, N.Z. : Craig Potton Publishing, 2007.Description: 237 p. ; 24 cmISBN:

9781877333705 (pbk.)

Subject(s):

Milk -- Health aspects

LOC classification:

RA602.M54 W66 2007

Contents:

Beginnings — Milk and casomorphins — Population studies of heart disease — The trials and science of heart disease — Population evidence for type 1 diabetes — Diabetic rodents and scientific disclosure — The science and big picture of type 1 diabetes — Autism and schizophrenia — Allergies, intolerance, and auto-immunity — Breeding A2 cows — The food safety game — Business battles: getting A2 milk to market — Bringing it all together.

Summary: This groundbreaking book is the first to be published internationally that examines the link between one of the proteins in the milk we drink and a range of serious illnesses, including heart disease, Type 1 diabetes, autism and schizophrenia. These health problems are linked to a tiny protein fragment that is formed when we digest A1 beta-casein, a milk protein produced by many cows in New Zealand, Australia and other western countries. Milk that contains A1 beta-casein is commonly known as A1 milk, whereas milk that does not is called A2. Originally all milk was A2 until a mutation affecting some European cattle occurred some thousands of years ago. Herds in much of Asia, Africa and parts of southern Europe remain naturally high in A2 cows. A2 milk from selected cows is now marketed in much of Australia, and in parts of the USA and New Zealand. In Devil in the Milk Keith Woodford, Professor of Farm Management and Agribusiness at Lincoln University in New Zealand, brings together the evidence published in more than 100 scientific papers. He examines the population studies that look at the link between the consumption of A1 milk and the incidence of heart disease and Type 1 diabetes; he explains the science that underpins the A1/A2 hypothesis; and examines the research undertaken with animals and humans. The evidence is compelling: we should be switching to A2 milk. This is an amazing story, one that is not just about the health issues surrounding A1 milk, but also how scientific evidence can be moulded and withheld by vested interests, and how consumer choices are influenced by the interests of corporate business. Now revised with a Postscript that updates the story to the present day, Devil in the Milk remains a book of enormous public importance.

List(s) this item appears in: HEALTH

Holdings ( 1 )
Title notes ( 3 )

Holdings
Item type	Current library	Call number	Copy number	Status	Notes	Date due	Barcode
Book	TBS Barcelona	RA602.M54 WOO (Browse shelf(Opens below))	1	Available	SOON AVAILABLE

Includes bibliography (p. 209-218) and index.

This groundbreaking book is the first to be published internationally that examines the link between one of the proteins in the milk we drink and a range of serious illnesses, including heart disease, Type 1 diabetes, autism and schizophrenia.

These health problems are linked to a tiny protein fragment that is formed when we digest A1 beta-casein, a milk protein produced by many cows in New Zealand, Australia and other western countries. Milk that contains A1 beta-casein is commonly known as A1 milk, whereas milk that does not is called A2. Originally all milk was A2 until a mutation affecting some European cattle occurred some thousands of years ago. Herds in much of Asia, Africa and parts of southern Europe remain naturally high in A2 cows. A2 milk from selected cows is now marketed in much of Australia, and in parts of the USA and New Zealand.

In Devil in the Milk Keith Woodford, Professor of Farm Management and Agribusiness at Lincoln University in New Zealand, brings together the evidence published in more than 100 scientific papers. He examines the population studies that look at the link between the consumption of A1 milk and the incidence of heart disease and Type 1 diabetes; he explains the science that underpins the A1/A2 hypothesis; and examines the research undertaken with animals and humans. The evidence is compelling: we should be switching to A2 milk.

This is an amazing story, one that is not just about the health issues surrounding A1 milk, but also how scientific evidence can be moulded and withheld by vested interests, and how consumer choices are influenced by the interests of corporate business. Now revised with a Postscript that updates the story to the present day, Devil in the Milk remains a book of enormous public importance.